owlgift.blogg.se

For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.

Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. The Novamind Shares will be delisted from the Canadian Securities Exchange ("CSE") and Novamind intends to submit an application to the applicable securities regulators to cease to be a reporting issuer and to terminate its public reporting obligations.įull details of the Transaction are described in the Company's management information circular dated May 6, 2022, which is available on the Company's SEDAR profile at About Novamind Holders of Novamind restricted share units ("Novamind RSUs") received the number of Numinus Shares equal to the number of Novamind Shares such holder was entitled to under each Novamind RSU, subject to any withholdings or deductions, multiplied by the Exchange Ratio. In addition, each Novamind option has been exchanged for replacement Numinus options that entitle the holders to receive, upon exercise thereof, Numinus Shares based upon the Exchange Ratio. Pursuant to the Transaction, Numinus acquired all of the common shares of Novamind ("Novamind Shares") and the holders of Novamind Shares have received 0.84 (the "Exchange Ratio") of a common share of Numinus (each a "Numinus Share") for each Novamind Share held. (TSX:NUMI)(OTCQX:NUMIF) ("Numinus") by way of a plan of arrangement (the "Transaction") following receipt of a final order from the Supreme Court of British Columbia. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Wellness Inc. Conformément à la Transaction, Numinus a acquis toutes les actions ordinaires de Novamind (« Actions Novamind ») et les détenteurs d'Actions Novamind ont reçu 0,84 (le « Rapport d'échange ») d'une action ordinaire de Numinus (chacun étant une « Action Numinus ») pour chaque Action Novamind détenue.TORONTO, ON / ACCESSWIRE / J/ Novamind Inc. au moyen d'un plan d'arrangement (la "Transaction") suite à la réception d'une commande finale de la Cour suprême de la Colombie-Britannique. ("Novamind" ou la "Société"), a annoncé que la Société a finalisé son acquisition précédemment annoncée par Numinus Wellness Inc. T he Novamind Shares will be delisted from the Canadian Securities Exchange (“CSE”) at market close June 13, 2022. Pursuant to the Transaction, Numinus acquired all of the common shares of Novamind (“ Novami nd Shares”) and the holders of Novamind Shares have receive d 0.84 (the “Exchange Ratio”) of a common share of Numinus ( each a “Numinus Share”) for each Novamind Share held.įull details of the Transaction are described in the Company’s management information circular dated May 6, 2022. by way of a plan of arrangement (the “Transaction”) following receipt of a final order from the Supreme Court of British Columbia. (“Novamind” or the “Company”), has announced that the Company has completed its previously announced acquisition by Numinus Wellness Inc.